⚫ Works by increasing the concentration of acetylcholine by inhibiting dopamine D2 receptors and acetylcholinesterase
⚫ A promising gastroprokinetic agent for FD because of its efficacy without any significant adverse events'
⚫ Regulates gastric motility and gastric emptying
⚫ Unlike other prokinetic drugs that are utilized in the management of Functional Dyspepsia, Acorun shows little or no affinity for serotonin or dopamine D2 receptors2
⚫ World's First Approved Treatment for Functional Dyspepsia in Patients Diagnosed by Rome III criteria2